Mesothelioma study to stop growth of mesothelin

A study of an antibody designed to stop the growth of mesothelin has begun. Mesothelin is a protein that is excessively produced in the tumors of mesothelioma patients.

86 participants are expected to take part in the study. The study is being conducted in clinical centers located in many different countries. The patients in the study have been diagnosed with locally advanced malignant pleural mesothelioma who have not received prior treatment.

If you or a loved one has been diagnosed with an asbestos illness like mesothelioma, lung cancer or asbestosis, complete the form on this page to get a FREE and prompt review of your case by a leading asbestos attorney. Weitz & Luxenberg is a leading mesothelioma law firm with a substantial history of success in asbestos exposure cases.